Forms Processing
PRODUCTS
-
Our bioanalytical services assist our customers in every stage of their molecule development.
-
Specialized knowledge and expertise in information technology, quality assurance and laboratory practices is required to successfully implement and maintain laboratory projects and informatics systems within the pharmaceutical, biotech, chemical, food, and environmental industries.
-
Applikon V-Control is a sole software platform for process control, process automation and data acquisition from research to production. It enables seamless transfer of data and technology to optimize bioprocesses.
-
Wearable Glass Devices
Wearable devices, or smart glasses, refer to a device that contains a computer screen or display in front of a person´s eyes that uses augmented reality or mixed reality to present data. Graphics or text are overlaid onto a user’s existing environment so that they can complete a task or engage in a new contextualized experience. As a result, users can continue to operate within his or her environment without distractions or obstruction when the digital content is not needed. -
The Model 75S6G18C is a solid-state, Class A design, self-contained, aircooled, broadband power amplifier designed for applications where instantaneous bandwidth, high gain and linearity are required.
WHITE PAPERS AND CASE STUDIES
-
Advancing Drug Development Using In Silico Modeling
Learn how in silico modeling can improve the likelihood of clinical success and return on investment for investigational new drug development.
-
A Site Network’s Experience With eSource Before And During COVID
Discover how the world's leading vaccine network adopted eSource during COVID-19 despite many obstacles that got in their way.
-
Leveraging The Bolar Exemption To Accelerate Market Access
Gain insight into the changing comparator sourcing landscape, focusing specifically on the instrumental role the Bolar exemption plays in the shift away from dependence on innovators for clinical supplies.
-
Driving Customer Profitability With Enterprise Platform, Pricing
Explore how the solutions and approaches offered by CDS can help different research stakeholders conduct more cost-efficient clinical trials in the industry's pharmaceutical, biotech, and device sectors.
-
A New Approach To Characterizing Crystalline Structure
Learn how the accuracy (melting temperature and heat of fusion) and utility of Differential Scanning Calorimetry data is greatly diminished for materials that undergo Apparent Melting and much more.
-
Key Considerations In Large-Molecule Orphan Drug Development
Explore guidance for overcoming challenges with orphan drugs and ensuring that enough high-quality data is generated from the start of your program to guide evidence-based decision making.
-
Evolving Trends And Recommendations For Breakthroughs In The ATMP Space
Identify and examine the key trends in the advanced therapy medicinal product (ATMP) industry, and explore impact companies across a range of concerns, including speed to market, efficiency, safety, and innovation.
-
A Five-Point Strategy For Building A CMC Dossier
By adopting strategies to build a robust CMC package to help streamline the path to FIH trials, innovators can establish a quality foundation to support their path toward commercialization.
-
How To Save 9k Hours And Cut Deviations By 27%
This pharma company transitioned off paper, slashing their deviation count and saving thousands in onsite hours. Learn how they were able to streamline business operations and free up resources.
-
DC Water's Digital Twin Solution
Explore how operational and financial resilience can be improved by implementing a water infrastructure digital twin.
-
How Newark’s Lead Pipe Replacement Program Sparked The Creation Of leadCAST
Learn about how helping Newark digitize their lead pipe replacement program served as the foundation for leadCAST, a cloud-based management system for Lead & Copper Rule program management.
-
The Role Of Real World Evidence To Support US FDA And TGA Registrations
Real world evidence (RWE) can contribute valuable information to new medicine registrations, in particular, for diseases that are difficult to assess in randomized clinical trials (RCTs) and for emerging technologies.
NEWS
-
AITX’s, Robotic Assistance Devices, Announces That Scotland Memorial Hospital Embraces RAD Light My Way™ For Staff Safety8/23/2023
Artificial Intelligence Technology Solutions, Inc., (the “Company”) (OTCPK:AITX), a global leader in AI-driven security and productivity solutions along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), today named Scotland Memorial Hospital as the initial healthcare deployment of RAD Light My Way.
-
Lithuanian Invention At The Forefront Of Solar Technology Breakthrough8/22/2023
29, 30, 32… – these are not random numbers, but the efficiency of solar cells, measured by the percentage of incidental sunlight they convert into electrical power.
-
Launching An AI And Photonics Initiative At Duke1/26/2024
AI and photonics have a long history with one another. As the nascent field of machine learning took hold in areas outside of niche programming applications in the 1990s, one of its first major successes was in image recognition.
-
Himax To Present Innovative Solutions For tinyML Opportunities With WiseEye™ AI During CES 202412/20/2023
Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced that during CES 2024 the Company will unveil its new generation WiseEyeTM AI processor, WE2, with a diverse array of new sensor fusion use cases, encompassing image, video and audio.
-
NUS Researchers Develop AI-Powered ‘Eye’ For Visually Impaired People To ‘See’ Objects2/19/2024
Shopping for groceries is a common activity for many of us, but for visually impaired people, identifying grocery items can be daunting